Glimepiride 1mg + Metformin 500mg Bi-Layer Sustained Release (SR) Tablet is an effective oral anti-diabetic formulation designed to manage type 2 diabetes mellitus. This combination therapy works by addressing different aspects of blood glucose control. Glimepiride stimulates the pancreas to release insulin, helping lower blood sugar levels. Metformin SR improves insulin sensitivity and reduces hepatic glucose production, maintaining steady glucose levels throughout the day. The bi-layer design ensures gradual release of Metformin, reducing gastrointestinal discomfort while providing long-lasting glycemic control. This combination is ideal for patients who require better glycemic control than monotherapy and prefer the convenience of a sustained-release tablet.
